You are here

  • Home
  • Archive
  • Volume 73, Issue 1
  • Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol

Citation Tools

Article menu
Clinical and epidemiological research
Concise report
Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
van der Heijde D, Fleischmann R, Wollenhaupt J, et al
Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol
Annals of the Rheumatic Diseases 2014;73:233-237.